- United States
- /
- Semiconductors
- /
- NasdaqGS:MCHP
Is Microchip Technology (MCHP) Getting Rich After Its Edge AI Deal?
Microchip Technology stock has gained 19.8% year to date, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market based multiples suggest the shares look relatively inexpensive.
- The 19.8% year to date return suggests investors have already priced in a fair amount of optimism about Microchip Technology.
- Planned expansion into edge AI through the Hailo acquisition may support expectations for future cash flows. However, integration execution and capital demands for these projects can add uncertainty to what those cash flows are ultimately worth.
- Microchip Technology scores 3 out of 6 on our valuation checks, which points to a mixed picture rather than a clear bargain or clear overvaluation.
The issue now is whether the current share price already reflects a fair balance between that premium DCF read and the more supportive signals from earnings and cash flow multiples.
Find out why Microchip Technology's 13.4% return over the last year is lagging behind its peers.
Is Microchip Technology Getting Expensive on Cash Flow?
The Discounted Cash Flow (DCF) model here estimates what Microchip Technology might be worth based on its projected cash generation. The latest twelve month free cash flow sits at about $821 million, and the model assumes those cash flows grow over time rather than shrink. On that basis, the DCF output points to an intrinsic value of about $67 per share.
Compared with the current share price, that intrinsic value implies Microchip Technology screens as around 15.4% overvalued. The pending Hailo acquisition, which pushes Microchip Technology further into edge AI, helps explain why the market is willing to pay above the cash flow based estimate. Investors are effectively paying up today for the potential of those additional AI related cash flows to strengthen the business over time.
On balance, the DCF workup suggests Microchip Technology stock looks overvalued at current levels.
Our Discounted Cash Flow (DCF) analysis suggests Microchip Technology may be overvalued by 15.4%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.
Is Microchip Technology Still Cheap on Sales?
P/S is often a useful cross check for Microchip Technology because revenue can be less volatile than earnings in semiconductors. The stock currently trades on a P/S of 9.0x, which is above the broader semiconductor industry average of 7.3x but sits well below the peer group average of 15.9x.
The tailored fair P/S ratio for Microchip Technology is 11.5x, based on factors such as its margins, size and risk profile. Against that benchmark, the current 9.0x implies the stock trades at a discount to what this framework would suggest, even after the recent share price strength and the attention around its push into edge AI. On this measure, the market does not appear to be paying a premium relative to the company specific sales profile.
Taken together, Microchip Technology appears undervalued on the P/S multiple compared with its modelled fair ratio.
See what the numbers say about this price — find out in our valuation breakdown.
The Microchip Technology Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Microchip Technology sit on the Community page and pick up where this valuation gap leaves off. They spell out which assumptions on growth, margins and earnings would need to play out for the stock to be worth a lot more or a lot less than today’s price. Each one links its number to a clear view on how Microchip Technology's growth, profitability and risks could evolve, which you can revisit as new information comes through.
One of the top community narratives on Microchip Technology: 31% undervalued
"The accelerating adoption of edge computing and proliferation of AI-enabled, connected devices is fueling demand for Microchip's portfolio of microcontrollers, analog, and FPGA solutions…"
Read one of the top narratives on Microchip Technology
Do you think there's more to the story for Microchip Technology? Head over to our Community to see what others are saying!
The Bottom Line
For Microchip Technology, the Discounted Cash Flow (DCF) work flags the stock as overvalued on a pure cash flow timing and capital intensity view, while the sales multiple suggests it still trades on an undervalued P/S relative to its tailored fair ratio. That split largely comes down to how much weight you place on near term cash generation versus longer term expectations for revenue and where peers are being priced. With the broader valuation checks sitting in the middle, the real hinge now is whether Microchip Technology converts its edge AI and related initiatives into durable, cash generative growth that justifies today’s mix of signals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:MCHP
Microchip Technology
Develops, manufactures, and sells smart, connected, and secure embedded control solutions in the Americas, Europe, and Asia.
High growth potential and fair value.
Similar Companies
Market Insights
Weekly Picks

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Zoetis down -50% over the past year

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.
Recently Updated Narratives

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend
WHERE DID THE SIX MILLION SHARES GO? THE PRG OWNERSHIP TRAIL INVESTORS CANNOT IGNORE

Compounder to Cash Generator in Real Time
Popular Narratives
A wonderful business at reasonable price.


